Gene · 3913
NIH grants2,633
NIH grants whose papers are about the gene, through NIH's grant-paper links.
821 to 840 of 2,633
Download this page as JSON| Grant | Title | LAMB2 papers | Newest fiscal year |
|---|---|---|---|
| R01MH049428 | Genetic Regulation of Telencephalon Development | 1 | 2022 |
| R01NS077986 | Pre-motor Neural Circuits for Exploratory Movement | 1 | 2022 |
| R01NS099102 | Molecular Mechanisms Controlling PNS Myelin Maintenance | 1 | 2022 |
| R01NS102261 | Surface ectodermal mechanism and maternal intervention of neural tube defects | 1 | 2022 |
| R01NS102360 | Bridging the gap: Angiogenesis and stem cell seeding of processed nerve allograft | 1 | 2022 |
| R01NS104219 | Determining How Defective Nucleo-Cytoplasmic Trafficking Leads To Neurodegeneration In C9orf72-Related ALS And FTD | 1 | 2022 |
| R01NS105961 | Develop a combinatorial therapy for spinal cord injury | 1 | 2022 |
| R01NS107548 | A novel strategy to overcome the P-gp/BCRP drug efflux system at the blood-brain barrier to improve brain uptake of CNS therapeutics | 1 | 2022 |
| R01NS109491 | Congenital Myasthenic Syndromes | 1 | 2022 |
| R01NS110387 | Brain Recovery after Cardiac Arrest with Metabolic Glycoengineered Stem Cells | 1 | 2022 |
| R01NS110388 | Distal mRNA localization and translation in neural stem cells of the developing brain | 1 | 2022 |
| R13EY034018 | RReSTORE: RGC Repopulation, Stem Cell Transplantation, and Optic Nerve Regeneration. | 1 | 2022 |
| R21AG075754 | Identifying shared and distinct cell type vulnerability across neurological diseases. | 1 | 2022 |
| R21AI154343 | Association of Staphylococcus aureus infection with autoimmunity in cystic fibrosis | 1 | 2022 |
| R21AI166772 | A Bioengineered Model for Deciphering Lymphatic Dysfunction in Inflammation | 1 | 2022 |
| R21CA252579 | Direct therapeutic intervention of the tumor microenvironment with a potent inhibitor of fibronectin assembly | 1 | 2022 |
| R21CA256615 | High-Resolution Dynamic Imaging of Ovarian Cancer Metastasis Post Chemotherapy | 1 | 2022 |
| R21DE031072 | RNA modification and the regulation of partial EMT in head and neck cancer | 1 | 2022 |
| R21DK131557 | Ultrabright Plasmonic-Fluor Nanosensor-Enabled Noninvasive Management of Pediatric Nephrotic Syndrome | 1 | 2022 |
| R21EY032742 | Hydrogen sulfide toxicity to the cornea | 1 | 2022 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3913/grants?page=42